Leg ulcer in a patient associated with hydroxyurea therapy

International Journal of Dermatology

Volumn 45, Issue 2, 2006, Pages 158-160

  Dissemond, Joachim ^a,b   Hoeft, Daniela ^a   Knab, Julia ^a   Franckson, Tom ^a   Kroger, Knut ^a   Goos, Manfred ^a  

^a University School of Medicine   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA; IODINE; POLY(HEXAMETHYLENEBIGUANIDE);

ADULT; ANAMNESIS; ARTICLE; CLINICAL EXAMINATION; DEBRIDEMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEG ULCER; LONG TERM CARE; LOW ENERGY RADIATION; MALE; SKIN BIOPSY; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; WOUND CARE; WOUND DRESSING; WOUND HEALING;

ALGINATES; ANTINEOPLASTIC AGENTS; BANDAGES; BIGUANIDES; DEBRIDEMENT; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; HYDROXYUREA; ISOTONIC SOLUTIONS; LEG ULCER; MALE; MIDDLE AGED; SKIN CARE; THROMBOCYTHEMIA, HEMORRHAGIC; ULTRASONIC THERAPY; WOUND HEALING;

EID: 33645966212     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02450.x     Document Type: Article

References (15)

1. Stock CC. Clarke DA, Phillips FS, et al. Sarcoma 180 screening data. Cancer Res 1960; 20: 193-381.
2. Najean Y, Rain JD. Treatment of polycythemia vera: The use of hydroxyurea and pipobroman in 292 patients under the age of 65 years. Blood 1997; 90: 3370-3377.
3. Weinlich G, Schuler G, Greil R, et al. Leg ulcers associated with long-term hydroxyurea therapy. J Am Acad Dermatol 1998; 39: 372-374.
4. Bader U, Banyai M, Boni R, et al. Leg ulcers in patients with myeloproliferative disorders: Disease- or treatment-related? Dermatology 2000; 200: 45-48.
5. Yarbro JW. Mechanism of action of hydroxyurea. Semin Oncol 1992; 19: 1-10.
6. Demircay Z, Comert A, Adiguzel C. Leg ulcers and hydroxyurea: Report of three cases with essential thrombocythemia. Int J Dermatol 2002; 41: 872-874.
7. Best PJ, Daoud MS, Pittelkow MR, et al. Hydroxyurea-induced leg ulceration in 14 patients. Ann Intern Med 1998; 128: 29-32.
8. Sirieix ME, Debure C, Baudot N, et al. Leg ulcers and hydroxyurea: forty-one cases. Arch Dermatol 1999; 135: 818-820.
9. Chaine B, Neonato MG, Girot R, et al. Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease. Arch Dermatol 2001; 137: 467-470.
10. Poros A, Nadasdy K. Leg ulcer in hydroxyurea-treated patients. Haematologia 2000; 30: 313-318.
11. Al-Momen AK. Recombinant human erythropoietin induced rapid healing of a chronic leg ulcer in a patient with sickle cell disease. Acta Haematol 1991; 86: 46-48.
12. Flores F, Eaglstein WA, Kirsner RS. Hydroxyurea-induced leg ulcers treated with Apligraf. Ann Intern Med 2000; 132: 417-418.
13. Stagno F, Guglielmo P, Consoli U, et al. Successful healing of hydroxyurea-related leg ulcers with topical granulocyte-macrophage colony-stimulating factor. Blood 1999; 94: 1479-1480.
14. Kido M, Tago O, Fujiwara H, et al. Leg ulcer associated with hydroxyurea treatment in a patient with chronic myelogenous leukaemia: Successful treatment with prostagladin E1 and pentoxifylline. Br J Dermatol 1998; 139: 1124-1126.
15. Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: A systematic approach to wound management. Wound Repair Regen 2003; 11: S1-S28.